PT3180339T - Derivados de 6-alcinil-piridina como miméticos de smac - Google Patents

Derivados de 6-alcinil-piridina como miméticos de smac

Info

Publication number
PT3180339T
PT3180339T PT15747820T PT15747820T PT3180339T PT 3180339 T PT3180339 T PT 3180339T PT 15747820 T PT15747820 T PT 15747820T PT 15747820 T PT15747820 T PT 15747820T PT 3180339 T PT3180339 T PT 3180339T
Authority
PT
Portugal
Prior art keywords
alkynyl
pyridine derivatives
smac mimetics
smac
mimetics
Prior art date
Application number
PT15747820T
Other languages
English (en)
Portuguese (pt)
Inventor
Reiser Ulrich
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PT3180339T publication Critical patent/PT3180339T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT15747820T 2014-08-11 2015-08-10 Derivados de 6-alcinil-piridina como miméticos de smac PT3180339T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14180554 2014-08-11

Publications (1)

Publication Number Publication Date
PT3180339T true PT3180339T (pt) 2019-02-27

Family

ID=51300621

Family Applications (1)

Application Number Title Priority Date Filing Date
PT15747820T PT3180339T (pt) 2014-08-11 2015-08-10 Derivados de 6-alcinil-piridina como miméticos de smac

Country Status (34)

Country Link
US (4) US9481673B2 (enExample)
EP (1) EP3180339B1 (enExample)
JP (1) JP6250226B2 (enExample)
KR (1) KR102445744B1 (enExample)
CN (2) CN106573930B (enExample)
AP (1) AP2017009718A0 (enExample)
AR (1) AR101479A1 (enExample)
AU (1) AU2015303308B2 (enExample)
BR (1) BR112017002498B1 (enExample)
CA (1) CA2956123C (enExample)
CL (1) CL2017000326A1 (enExample)
CO (1) CO2017001226A2 (enExample)
CY (1) CY1121273T1 (enExample)
DK (1) DK3180339T3 (enExample)
EA (1) EA031424B1 (enExample)
ES (1) ES2711763T3 (enExample)
HR (1) HRP20190336T1 (enExample)
HU (1) HUE043915T2 (enExample)
IL (1) IL249844B (enExample)
LT (1) LT3180339T (enExample)
ME (1) ME03303B (enExample)
MX (1) MX2017001835A (enExample)
NZ (1) NZ728073A (enExample)
PE (1) PE20170193A1 (enExample)
PH (1) PH12017500231A1 (enExample)
PL (1) PL3180339T3 (enExample)
PT (1) PT3180339T (enExample)
RS (1) RS58355B1 (enExample)
SG (1) SG11201700999YA (enExample)
SI (1) SI3180339T1 (enExample)
TR (1) TR201902023T4 (enExample)
TW (1) TWI723959B (enExample)
UA (1) UA118887C2 (enExample)
WO (1) WO2016023858A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR101479A1 (es) * 2014-08-11 2016-12-21 Boehringer Ingelheim Int Derivados de 6-alquinil-piridina
WO2017198734A1 (en) * 2016-05-19 2017-11-23 Boehringer Ingelheim International Gmbh Process for the manufacture of 6-alkynyl-pyridine derivatives
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
AU2018241944A1 (en) * 2017-03-31 2019-08-15 Boehringer Ingelheim International Gmbh Anticancer combination therapy
EP3886842A1 (en) 2018-11-26 2021-10-06 Debiopharm International SA Combination treatment of hiv infections
TWI894135B (zh) * 2019-01-25 2025-08-21 德商百靈佳殷格翰國際股份有限公司 編碼ccl21之重組棒狀病毒
BR112022005624A2 (pt) 2019-09-25 2022-07-12 Debiopharm Int Sa Regimes de dosagem para tratamento de pacientes com carcinoma de células escamosas localmente avançado
MX2022015261A (es) 2020-06-03 2023-03-14 Boehringer Ingelheim Int Rhabdovirus recombinante que codifica una proteina de fusion fc de dominio extracelular cd80.
WO2024175554A1 (en) 2023-02-21 2024-08-29 Institut Curie Trail agonists for use in the treatment of cancer in patients having an activating alteration of fgfr3

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060234360A1 (en) 2005-04-13 2006-10-19 Paola Branduardi Ascorbic acid production from D-glucose in yeast
JP2008545780A (ja) 2005-06-08 2008-12-18 ノバルティス アクチエンゲゼルシャフト 有機化合物
WO2007101347A1 (en) 2006-03-07 2007-09-13 Aegera Therapeutics Inc. Bir domain binding compounds
WO2008073306A1 (en) 2006-12-07 2008-06-19 Novartis Ag Organic compounds
US8859541B2 (en) 2012-02-27 2014-10-14 Boehringer Ingelheim International Gmbh 6-alkynylpyridines
US9278978B2 (en) 2013-08-23 2016-03-08 Boehringer Ingelheim International Gmbh 6-Alkynyl Pyridine
US9249151B2 (en) 2013-08-23 2016-02-02 Boehringer Ingelheim International Gmbh Bis-amido pyridines
AR101479A1 (es) 2014-08-11 2016-12-21 Boehringer Ingelheim Int Derivados de 6-alquinil-piridina

Also Published As

Publication number Publication date
BR112017002498B1 (pt) 2022-10-11
JP6250226B2 (ja) 2017-12-20
US20190358218A1 (en) 2019-11-28
AR101479A1 (es) 2016-12-21
ES2711763T3 (es) 2019-05-07
US9481673B2 (en) 2016-11-01
NZ728073A (en) 2022-10-28
US20180015082A1 (en) 2018-01-18
TWI723959B (zh) 2021-04-11
TR201902023T4 (tr) 2019-03-21
CA2956123C (en) 2023-02-14
EP3180339B1 (en) 2018-12-05
CA2956123A1 (en) 2016-02-18
SG11201700999YA (en) 2017-03-30
EP3180339A1 (en) 2017-06-21
RS58355B1 (sr) 2019-03-29
LT3180339T (lt) 2019-02-25
EA201790349A1 (ru) 2017-07-31
PH12017500231A1 (en) 2017-07-03
HRP20190336T1 (hr) 2019-05-03
US9801871B2 (en) 2017-10-31
PE20170193A1 (es) 2017-03-25
SI3180339T1 (sl) 2019-03-29
CN111440164A (zh) 2020-07-24
EA031424B1 (ru) 2018-12-28
HUE043915T2 (hu) 2019-09-30
CN106573930A (zh) 2017-04-19
US20160039814A1 (en) 2016-02-11
KR102445744B1 (ko) 2022-09-20
US20170020859A1 (en) 2017-01-26
WO2016023858A1 (en) 2016-02-18
BR112017002498A2 (pt) 2017-12-05
MX2017001835A (es) 2017-04-27
AP2017009718A0 (en) 2017-01-31
KR20170036095A (ko) 2017-03-31
CO2017001226A2 (es) 2017-05-10
CN106573930B (zh) 2020-03-03
CY1121273T1 (el) 2020-05-29
DK3180339T3 (en) 2019-03-04
IL249844A0 (en) 2017-03-30
UA118887C2 (uk) 2019-03-25
IL249844B (en) 2019-03-31
CL2017000326A1 (es) 2017-10-20
US10413536B2 (en) 2019-09-17
TW201619156A (zh) 2016-06-01
AU2015303308B2 (en) 2020-01-30
JP2017524013A (ja) 2017-08-24
PL3180339T3 (pl) 2019-05-31
CN111440164B (zh) 2023-02-17
AU2015303308A1 (en) 2017-02-02
ME03303B (me) 2019-07-20

Similar Documents

Publication Publication Date Title
IL249844A0 (en) History of 6-alkynylpyridine as smac-like agents
IL252777A0 (en) A dihydroindolizinone derivative
SG11201609205WA (en) Heterocyclyl-butanamide derivatives
PL3418273T3 (pl) Pochodne flawaglin
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
IL248773A0 (en) History of naphthyridinedione
IL248629B (en) Substances containing diheteroaryl conjugated to cycloalkyl and their uses
PL3097076T3 (pl) Nowe pochodne CYP-eikozanoidowe
IL248772A0 (en) A consequence of cyclohexyl pyridine
PL3119744T3 (pl) Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu
PL3000955T3 (pl) Układ oszklenia
GB201414421D0 (en) Techflush unit
AU360267S (en) Bracket
AU359675S (en) Bracket
HU4371U (en) Cable-holder unit
AU355469S (en) Bracket
AU355468S (en) Bracket